MPT Resource Center

Introducing New Contraceptive Options: Product Registration Basics for Global Health Program Managers

Introducing New Contraceptive Options: Product Registration Basics for Global Health Program Managers In this Report: Topic(s): Regulatory Pathways Global Health Contraception

TRIO Study Brief: Long-Acting Injections for Women’s HIV Prevention in Sub-Saharan Africa: What End-Users Think

TRIO MPT Research Brief: Listening to Young Women in Kenya and South Africa to Inform Multipurpose “2-in-1” Products for HIV and Pregnancy Prevention

TRIO General Research Brief: What End-Users Think About HIV Prevention Products and Multipurpose Prevention Technologies (MPT)

Toward a Roadmap for Biomedical HIV Prevention Investment Standards: Strategic Insights from Key Industry Stakeholders

Market Access Framework for Multipurpose Prevention Technology (MPT) Development and Introduction

Market Access Framework for Multipurpose Prevention Technology (MPT) Development and Introduction April 2019 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): MPTs Product Development Product Trials

Traditional Socio-Behavioral Research and Human-Centered Design: Similarities, Unique Contributions and Synergies

This report by Dr. Betsy Tolley (FHI 360) presents learnings and reflections on traditional socio-behavioral research (SBR) and human-centered design (HCD) as applied to the global health context – specifically in biomedical prevention for sexual and reproductive health. In comparing these methodologies and examining their strengths and shortcomings, we can identify potential synergies to further […]

Join the MPT development collaboration

Join the MPT development collaboration November 2017 click to view Technical Brief In this Technical Brief: Topic(s): Product Development SRH Linkages Region(s): Global Working Group(s): (SAWG) Scientific Agenda Working Group

Strategic Evaluation Framework (SEF) for MPTs: Strategic Target Profile (STP) context summaries

Strategic Evaluation Framework (SEF) for MPTs: Strategic Target Profile (STP) context summaries October 2017 Building upon the IMPT’s report: “Laying the Groundwork for a Strategic Evaluation Framework (SEF) for HIV Prevention and MPT Product Development,” the IMPT initiated the next steps to create a Strategic Target Profile (STP) for the dominant MPT product strategies in […]

MPTs: Building momentum through awareness-raising and advocacy

MPTs: Building momentum through awareness-raising and advocacy July 2017 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV STI / STD Unintended Pregnancy Topic(s): Advocacy Education Product Development Social/Behavioral Context Region(s): Global

Building capacity for MPT product development

Building capacity for MPT product development July 2017 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV STI / STD Unintended Pregnancy Topic(s): Policy Product Development Public-Private Partnerships Regulatory Issues Region(s): Global

Building MPT acceptability during product development through consumer and health systems research

Building MPT acceptability during product development through consumer and health systems research July 2017 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV STI / STD Unintended Pregnancy Topic(s): Product Development Product Introduction / Uptake Public-Private Partnerships Regulatory Issues Social/Behavioral Context Region(s): Global

Status of Modelling Efforts in the Field of Multipurpose Prevention Technologies: Summary Report

Status of Modelling Efforts in the Field of Multipurpose Prevention Technologies: Summary Report February 2017 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): ARVs IVR (Intravaginal Rings) MPTs Vaginal Cream/Gel Vaginal Film Topic(s): Collective Impact Education MPTs Risk

Laying the Groundwork for a Strategic Evaluation Framework (SEF) for HIV Prevention and MPT Product Development

Laying the Groundwork for a Strategic Evaluation Framework (SEF) for HIV Prevention and MPT Product Development 30 September 2016 This report outlines the methodology and results of an IMPT Secretariat project that was funded by USAID’s Office of HIV/AIDS, the objective of which was to create the foundation for a Strategic Evaluation Framework (SEF) for […]

Clinical Trial Evaluation Workshop for MPTs: Strategic Steps to Ensure Success

Clinical Trial Evaluation Workshop for MPTs: Strategic Steps to Ensure Success 13-14 September 2016 Washington, DC, USA click to view Technical Brief In this Technical Brief: Topic(s): Product Trials

2015 IMPT Priority Issues Identification Exercise

2015 IMPT Priority Issues Identification Exercise 2015 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV STI / STD Unintended Pregnancy Topic(s): Education Funding MPTs Region(s): Global

Drug Interactions between Hormonal Contraceptive Methods and Anti-Retroviral Medications Used to Treat HIV

Drug Interactions between Hormonal Contraceptive Methods and Anti-Retroviral Medications Used to Treat HIV October 2014 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV Unintended Pregnancy Product Type(s): ARVs Hormonal Contraceptives Topic(s): Drug Interactions Risk Region(s): Global

MPT Product Prioritization and Gap Analysis: 2014 Summary

MPT Product Prioritization and Gap Analysis: 2014 Summary 2014 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV HPV HSV STI / STD Unintended Pregnancy Product Type(s): ARVs Hormonal Contraceptives IVR (Intravaginal Rings) Vaginal Film Region(s): Africa China Europe India United States Working Group(s): (SAWG) Scientific Agenda Working Group (SACC) Supporting Agency […]

MPT Dosage-Form Specific Target Product Profiles (TPPs)

MPT Dosage-Form Specific Target Product Profiles (TPPs) 2014 In 2012, Initiative for Multipurpose Prevention Technologies (IMPT) managed an exercise to define general target attributes for MPT products. While prioritizing specific MPT product dosage forms (i.e., long acting injectables, intravaginal rings, and on-demand products), it became clear that it was necessary to move beyond a listing […]